MEI Pharma (MEIP) Short Interest Ratio & Short Volume

Short interest is the volume of MEI Pharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 20,900 shares of MEIP short. 0.34% of MEI Pharma's shares are currently sold short. Learn More on MEI Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MEIP shares currently have a short interest ratio of 1.0. Learn More on MEI Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.34% of MEI Pharma's floating shares are currently sold short.

MEI Pharma saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 20,900 shares, an increase of 167.9% from the previous total of 7,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

MEI Pharma currently has issued a total of 6,660,000 shares. Some of MEI Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. MEI Pharma currently has a public float of 6,150,000 shares.

0.34% of MEI Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to MEI Pharma: Alaunos Therapeutics, Inc. (9.51%), Sol-Gel Technologies Ltd. (0.10%), Synlogic, Inc. (0.53%), Onconova Therapeutics, Inc. (0.12%), BioVie Inc. (2.78%), KALA BIO, Inc. (0.21%), RenovoRx, Inc. (0.45%), Flora Growth Corp. (7.33%), TherapeuticsMD, Inc. (0.41%), Aptorum Group Limited (1.89%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling MEIP is an investing strategy that aims to generate trading profit from MEI Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for MEI Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MEIP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEIP, twice per month. The most recent reporting period available is April, 15 2024.